Efficacy and Safety of Intravitreal Conbercept With Modified Treat-and-Extend Regimens in Exudative AMD

Clinical trial NCT05539235 · UNKNOWN

Trial details

NCT number

NCT05539235

Sponsor

First Affiliated Hospital of Chongqing Medical University

Status

UNKNOWN

Phase

Phase 2, Phase 3

Study type

INTERVENTIONAL

Start date

2018-11-12

Primary completion

2023-08-01

Enrollment

60

View on ClinicalTrials.gov